Stock BIOV BIOVAXYS TECHNOLOGY CORP.
Add to a list
To use this feature you must be a member
Log inSign up

All News BioVaxys Technology Corp.

Equities

BIOV

CA09076M1014

Market Closed - Canadian Securities Exchange
Other stock markets
 20:35:54 15/05/2024 BST 		5-day change 1st Jan Change
0.07 CAD 0.00% Intraday chart for BioVaxys Technology Corp. -6.67% +40.00%
04-30 BioVaxys Technology Corp. Appoints Christopher Cherry as Chief Financial Officer CI
04-10 Biovaxys and SpayVac-For-Wildlife, Inc. Announce Launch of Field Trial for Large-Scale Immunocontraception in the Commercial Aquatic Farming Industry CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement
AQ
BioVaxys Technology Corp. Closes First Tranche of Private Placement
AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
AQ
BioVaxys Technology Corp. Appoints Christopher Cherry as Chief Financial Officer
CI
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
Biovaxys and SpayVac-For-Wildlife, Inc. Announce Launch of Field Trial for Large-Scale Immunocontraception in the Commercial Aquatic Farming Industry
CI
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY
AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMage
CI
BioVaxys Technology Plans Private Placement; Down 5.9%
MT
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT
AQ
BioVaxys Technology Corp. announced that it expects to receive CAD 1 million in funding
CI
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
Down 17%, BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
MT
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
BioVaxys Technology Corp. Announces Allowance of DPX-Related Patent for Japan and Filing of Additional International Patent Applications
CI
Annual Financial Statements Update for the Year Ended October 31, 2023
AQ
Biovaxys Completes The Acquisition Of All Intellectual Property And Clinical Stage Assets Of The Former IMV Inc.
MT
BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIOV Stock
  4. News BioVaxys Technology Corp.